These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12830733)

  • 1. Targeted therapies for the treatment of leukemia.
    Stull DM
    Semin Oncol Nurs; 2003 May; 19(2):90-7. PubMed ID: 12830733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Arsenic treatment for leukemia: new model of human cancer target treatment].
    Zhao WW; Chen SJ
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):439-40. PubMed ID: 15854545
    [No Abstract]   [Full Text] [Related]  

  • 3. Old, new drugs and new, new drugs for the new millennium.
    Scheinberg DA
    Curr Oncol Rep; 2000 Mar; 2(2):112-3. PubMed ID: 11122831
    [No Abstract]   [Full Text] [Related]  

  • 4. Innovations in antineoplastic therapy.
    Kaplow R
    Nurs Clin North Am; 2005 Mar; 40(1):77-94. PubMed ID: 15733948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From dissection of disease pathogenesis to elucidation of mechanisms of targeted therapies: leukemia research in the genomic era.
    Zhou GB; Li G; Chen SJ; Chen Z
    Acta Pharmacol Sin; 2007 Sep; 28(9):1434-49. PubMed ID: 17723177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis, treatment, and nursing care of acute leukemia.
    Viele CS
    Semin Oncol Nurs; 2003 May; 19(2):98-108. PubMed ID: 12830734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic cell transplantation in the treatment of leukemia.
    Devine H; DeMeyer E
    Semin Oncol Nurs; 2003 May; 19(2):118-32. PubMed ID: 12830736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in Philadelphia chromosome-positive malignancies: the potential role of arsenic trioxide.
    O'Dwyer ME; La Rosée P; Nimmanapalli R; Bhalla KN; Druker BJ
    Semin Hematol; 2002 Apr; 39(2 Suppl 1):18-21. PubMed ID: 12012318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis, treatment, and nursing care of patients with chronic leukemia.
    Breed CD
    Semin Oncol Nurs; 2003 May; 19(2):109-17. PubMed ID: 12830735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alemtuzumab (Campath 1-H).
    Schaal AD
    Clin J Oncol Nurs; 2005 Oct; 9(5):630-2. PubMed ID: 16235592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute myelogenous leukemia: advances and limitations of treatment.
    Parisi E; Draznin J; Stoopler E; Schuster SJ; Porter D; Sollecito TP
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Mar; 93(3):257-63. PubMed ID: 11925533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel agents aiming at specific molecular targets increase chemosensitivity and overcome chemoresistance in hematopoietic malignancies.
    Boehrer S; Nowak D; Hoelzer D; Mitrou PS; Chow KU
    Curr Pharm Des; 2006; 12(1):111-28. PubMed ID: 16454729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nursing considerations for nontraditional treatment approaches to hematologic malignancies.
    ONS News; 2004; 19(9 Suppl):67-8. PubMed ID: 15478594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decision-making in the diagnosis and treatment of leukemia.
    Shannon-Dorcy K; Wolfe V
    Semin Oncol Nurs; 2003 May; 19(2):142-9. PubMed ID: 12830738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of targeted treatments in cancer.
    Abou-Jawde R; Choueiri T; Alemany C; Mekhail T
    Clin Ther; 2003 Aug; 25(8):2121-37. PubMed ID: 14512124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic strategies for patients with relapsed acute promyelocytic leukemia].
    Ohnishi K
    Rinsho Ketsueki; 2006 Aug; 47(8):717-23. PubMed ID: 16986710
    [No Abstract]   [Full Text] [Related]  

  • 17. Leukemia, an effective model for chemical biology and target therapy.
    Chen GQ; Wang LS; Wu YL; Yu Y
    Acta Pharmacol Sin; 2007 Sep; 28(9):1316-24. PubMed ID: 17723165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody therapy of leukaemias and lymphomas.
    Jacobs SA; Foon KA
    Expert Opin Biol Ther; 2005 Sep; 5(9):1225-43. PubMed ID: 16120052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imatinib mesylate, the first molecularly targeted gene suppressor.
    Pindolia VK; Zarowitz BJ
    Pharmacotherapy; 2002 Oct; 22(10):1249-65. PubMed ID: 12389876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular target therapy for malignant tumors].
    Nihon Naika Gakkai Zasshi; 2005 Feb; 94 Suppl():76-80. PubMed ID: 15796061
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.